Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)
Clinical trial NCT06167291 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06167291
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-19
- Primary completion
- 2027-12-09
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.